Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Pliant Therapeutics Inc. (PLRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 6,000,000 | $8,100,000 | 0.45% | |
| 2. | Deep Track Capital David Kroin | 5,399,681 | $7,289,569 | -10% | 0.24% |
| 3. | Cormorant Asset Management Bihua Chen | 3,000,000 | $4,050,000 | 0.3% | |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,514,084 | $3,394,013 | +1876% | 0.02% |
| 5. | Redmile Group Jeremy Green | 2,053,559 | $2,772,305 | -30% | 0.26% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.20 | 52,419 | $587,150.46 | 430,517 | 2025-01-17 | Filing | |
| $11.20 | 20,148 | $225,679.76 | 262,608 | 2025-01-17 | Filing | |
| $11.20 | 15,936 | $178,500.73 | 211,558 | 2025-01-17 | Filing | |
| $11.20 | 18,478 | $206,973.93 | 194,574 | 2025-01-17 | Filing | |
| $11.20 | 3,740 | $41,892.11 | 24,550 | 2025-01-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,241,759 | $7,076,375 | 0% | |
| 2. | 3,334,575 | $4,501,677 | 0% | |
| 3. | 3,051,514 | $4,119,544 | 0% | |
| 4. | 2,969,199 | $4,008,419 | 1.29% | |
| 5. | 2,645,546 | $3,571,487 | 0% |
News See All
15 Most Shorted Stocks That Are Loved By Analysts
In this piece, we will take a look at the 15 most shorted stocks that are loved by analysts.
12 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 12 stocks with biggest upside potential according to analysts.
Harvard University's Latest Portfolio: 10 Best Biotech Stock Picks
In this article, we will look at Harvard University's latest stock portfolio and list its 10 best biotech stock picks.
10 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green's Redmile Group
In this article, we discuss the 10 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Is PLRX A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.